AP NEWS

Global Impetigo Treatment Market 2019-2023: Low Cost of Treatment / Side Effects of Drugs / Competitive Landscape - ResearchAndMarkets.com

December 19, 2018

DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The “Global Impetigo Treatment Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering.

The impetigo treatment market will register a CAGR of about 7% by 2023.

The evolving resistance of microorganisms is likely to push growth in the market. There has been evolving resistance owing to the frequent usage of oral antibiotics. Hence manufacturers are developing more effective antibiotics to treat skin infections.

Market Overview

Low cost of treatment

Impetigo is a common, highly contagious bacterial skin infection. However, the infection can be treated easily without spending much.

Side effects of drugs

Impetigo is a bacterial infection of the skin which is treated with topical antibiotics or oral drugs. However, few side effects of these drugs may pose a challenge to the market.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including Cutanea Life Sciences and GlaxoSmithKline, the competitive environment is quite intense.

Factors such as the low cost of treatment and the low cost of treatment, will provide considerable growth opportunities to impetigo treatment manufactures. Cutanea Life Sciences, GlaxoSmithKline, LEO Pharma, and Medimetriks Pharmaceuticals are some of the major companies covered in this report.

With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the markets competitive landscape and offering information on the products offered by companies.

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

Market ecosystem Market characteristics Market segmentation analysis

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

Market sizing 2018 Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

Bargaining power of buyers Bargaining power of suppliers Threat of new entrants Threat of substitutes Threat of rivalry Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product Comparison by product Topical - Market size and forecast 2018-2023 Oral - Market size and forecast 2018-2023 Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: SEGMENTATION BY DRUG CLASS

PART 10: GEOGRAPHIC LANDSCAPE

Geographic segmentation Geographic comparison Key leading countries Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

PART 15: VENDOR ANALYSIS

Vendors covered Vendor classification Market positioning of vendors Cutanea Life Sciences GlaxoSmithKline LEO Pharma Medimetriks Pharmaceuticals

For more information about this report visit https://www.researchandmarkets.com/research/h2n8rz/global_impetigo?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181219005639/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Dermatological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/19/2018 12:40 PM/DISC: 12/19/2018 12:40 PM

http://www.businesswire.com/news/home/20181219005639/en

AP RADIO
Update hourly